<?xml version="1.0" encoding="UTF-8"?>
<rss  xmlns:atom="http://www.w3.org/2005/Atom" 
      xmlns:media="http://search.yahoo.com/mrss/" 
      xmlns:content="http://purl.org/rss/1.0/modules/content/" 
      xmlns:dc="http://purl.org/dc/elements/1.1/" 
      version="2.0">
<channel>
<title>Samee Ullah</title>
<link>https://ullahsamee.github.io/posts.html</link>
<atom:link href="https://ullahsamee.github.io/posts.xml" rel="self" type="application/rss+xml"/>
<description>Samee Ullah is a Computational Structural Biologist</description>
<image>
<url>https://ullahsamee.github.io/files/ullah-samee-profile.jpeg</url>
<title>Samee Ullah</title>
<link>https://ullahsamee.github.io/posts.html</link>
</image>
<generator>quarto-1.3.353</generator>
<lastBuildDate>Mon, 25 Sep 2023 19:00:00 GMT</lastBuildDate>
<item>
  <title>De novo design of anti-variant COVID-19 vaccine</title>
  <dc:creator>Samee Ullah</dc:creator>
  <link>https://ullahsamee.github.io/posts/2023-10-Denovo-design-of-anti-variant-COVID-vaccine/index.html</link>
  <description><![CDATA[ 



<!--Include academic icons or bottons-->
<!-- 
Load Academicons v1: https://jpswalsh.github.io/academicons/
-->
<p><link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/jpswalsh/academicons@1/css/academicons.min.css"></p>
<p><link rel="stylesheet" href="http://maxcdn.bootstrapcdn.com/font-awesome/4.3.0/css/font-awesome.min.css"></p>
<!---
The following code are needed to show dimension citation and altmetrics.
https://api.altmetric.com/embeds.html
https://badge.dimensions.ai/
--->
<script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script>
<script async="" src="https://badge.dimensions.ai/badge.js" charset="utf-8"></script>
<div class="callout callout-style-default callout-note callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Paper
</div>
</div>
<div class="callout-body-container callout-body">
<p>Arpita Goswami, S. Madan Kumar, <strong>Samee Ullah</strong>, Milind M. Gore<br>
<em>Biology Methods and Protocols | Oxford Academic</em> (2023)<br>
DOI: <a href="https://academic.oup.com/biomethods/article/8/1/bpad021/7282982">10.1093/biomethods/bpad021</a></p>
</div>
</div>
<section id="abstract" class="level2">
<h2 class="anchored" data-anchor-id="abstract">Abstract</h2>
<p>Recent studies highlight the effectiveness of hybrid Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) vaccines combining wild-type nucleocapsid and Spike proteins. We have further enhanced this strategy by incorporating delta and omicron variants‚Äô spike protein mutations. Both delta and omicron mark the shifts in viral transmissibility and severity in unvaccinated and vaccinated patients. So their mutations are highly crucial for future viral variants also. Omicron is particularly adept at immune evasion by mutating spike epitopes. The rapid adaptations of Omicron and sub-variants to spike-based vaccines and simultaneous transmissibility underline the urgency for new vaccines in the continuous battle against SARS-CoV-2. Therefore, we have added three persistent T-cell-stimulating nucleocapsid peptides similar to homologous sequences from seasonal Human Coronaviruses (HuCoV) and an envelope peptide that elicits a strong T-cell immune response. These peptides are clustered in the hybrid spike‚Äôs cytoplasmic region with non-immunogenic linkers, enabling systematic arrangement. AlphaFold (Artificial intelligence-based model building) analysis suggests omitting the transmembrane domain enhances these cytoplasmic epitopes‚Äô folding efficiency which can ensure persistent immunity for CD4+ structural epitopes. Further molecular dynamics simulations validate the compact conformation of the modeled structures and a flexible C-terminus region. Overall, the structures show stability and less conformational fluctuation throughout the simulation. Also, the AlphaFold predicted structural epitopes maintained their folds during simulation to ensure the specificity of CD4+ T-cell response after vaccination. Our proposed approach may provide options for incorporating diverse anti-viral T-cell peptides, similar to HuCoV, into linker regions. This versatility can be promising to address outbreaks and challenges posed by various viruses for effective management in this era of innovative vaccines..</p>
</section>
<section id="links" class="level2">
<h2 class="anchored" data-anchor-id="links">Links</h2>
<p>Published <a href="https://academic.oup.com/biomethods/article/8/1/bpad021/7282982">paper</a></p>
<p>Researchgate <a href="https://www.researchgate.net/publication/374198130_De_novo_design_of_anti-variant_COVID-19_Vaccine">pdf</a></p>
<script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script>
<div class="altmetric-embed" data-badge-popover="right" data-badge-type="donut" data-doi="https://doi.org/10.1093/biomethods/bpad021">

</div>
<script async="" src="https://badge.dimensions.ai/badge.js" charset="utf-8"></script>
<!--Include social share buttons-->
<!-- 
AddToAny check more: https://www.addtoany.com/buttons/for/website 
Using includes will make edits easier, will only need to add or remove button here if needed.
https://quarto.org/docs/authoring/includes.html
-->
<div class="a2a_kit a2a_kit_size_32 a2a_default_style">
<p><a class="a2a_dd" href="https://www.addtoany.com/share"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_mastodon"></a> <a class="a2a_button_facebook"></a> <a class="a2a_button_email"></a></p>
</div>
<script async="" src="https://static.addtoany.com/menu/page.js"></script>


</section>

<div id="quarto-appendix" class="default"><section class="quarto-appendix-contents"><h2 class="anchored quarto-appendix-heading">Citation</h2><div><div class="quarto-appendix-secondary-label">BibTeX citation:</div><pre class="sourceCode code-with-copy quarto-appendix-bibtex"><code class="sourceCode bibtex">@article{ullah2023,
  author = {Ullah, Samee},
  title = {De Novo Design of Anti-Variant {COVID-19} Vaccine},
  volume = {8},
  number = {1},
  date = {2023-09-26},
  url = {https://academic.oup.com/biomethods/article/8/1/bpad021/7282982},
  doi = {10.1093/biomethods/bpad021},
  langid = {en}
}
</code></pre><div class="quarto-appendix-secondary-label">For attribution, please cite this work as:</div><div id="ref-ullah2023" class="csl-entry quarto-appendix-citeas">
Ullah, Samee. 2023. <span>‚ÄúDe Novo Design of Anti-Variant COVID-19
Vaccine‚Äù</span> 8 (1). <a href="https://doi.org/10.1093/biomethods/bpad021">https://doi.org/10.1093/biomethods/bpad021</a>.
</div></div></section></div> ]]></description>
  <category>paper</category>
  <guid>https://ullahsamee.github.io/posts/2023-10-Denovo-design-of-anti-variant-COVID-vaccine/index.html</guid>
  <pubDate>Mon, 25 Sep 2023 19:00:00 GMT</pubDate>
  <media:content url="https://ullahsamee.github.io/posts/2023-10-Denovo-design-of-anti-variant-COVID-vaccine/featured.png" medium="image" type="image/png" height="48" width="144"/>
</item>
<item>
  <title>Computational insights on the destabilizing mutations in the binding site of 3CL-protease SARS-CoV-2 Omicron (VOC)</title>
  <dc:creator>Samee Ullah* correspondence</dc:creator>
  <link>https://ullahsamee.github.io/posts/2023-04-12-Computational-insights-on-destabilizing-mutations-in-bindingsite-3clprotease-sarscov2-omicron/index.html</link>
  <description><![CDATA[ 



<!--Include academic icons or bottons-->
<!-- 
Load Academicons v1: https://jpswalsh.github.io/academicons/
-->
<p><link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/jpswalsh/academicons@1/css/academicons.min.css"></p>
<p><link rel="stylesheet" href="http://maxcdn.bootstrapcdn.com/font-awesome/4.3.0/css/font-awesome.min.css"></p>
<!---
The following code are needed to show dimension citation and altmetrics.
https://api.altmetric.com/embeds.html
https://badge.dimensions.ai/
--->
<script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script>
<script async="" src="https://badge.dimensions.ai/badge.js" charset="utf-8"></script>
<div class="callout callout-style-default callout-note callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Paper
</div>
</div>
<div class="callout-body-container callout-body">
<p><strong>Samee Ullah</strong> <a href="https://www.biorxiv.org/content/10.1101/2023.05.24.542061v1">doi: https://doi.org/10.1101/2023.05.24.542061</a> <em>bioArxive</em> (2023)<br>
DOI: <a href="https://www.biorxiv.org/content/10.1101/2023.05.24.542061v1">https://doi.org/10.1101/2023.05.24.542061</a><br>
<!--<i class="fa fa-download"></i> [PDF](/files/papers/2023-Computational-insightsonthedestabilizingmutationsinthebindingsiteof3cl-proteasesarscov2omicron.pdf) &nbsp; <i class="fa-brands fa-github"></i> --></p>
</div>
</div>
<p>#<a href="https://www.biorxiv.org/content/10.1101/2023.05.24.542061v1"><img src="https://ullahsamee.github.io/posts/2023-04-12-Computational-insights-on-destabilizing-mutations-in-bindingsite-3clprotease-sarscov2-omicron/featured.png" class="img-fluid" data-fig-align="center"></a></p>
<section id="abstract" class="level2">
<h2 class="anchored" data-anchor-id="abstract">Abstract</h2>
<p>The COVID-19 (Corona Virus Disease 19) pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is causing enormous difficulties in the worlds economies and there is uncertainty as to whether the current prophylactic measures will offer adequate protection globally after the appearance of virus variants that like that indicated as Omicron emerged in the presence of global vaccine-based immunization. While several studies are available describing the main differences in the spike protein of Omicron compared to the other variants previously emerged there was no structural insights into the 3CL-protease (3CLpro) associated to the new variant. Herein we performed a computational study based on genomic data and amino acid sequences available in the most updated COVID-19-related databases that allowed us to build up in silico the 3D structure of Omicron 3CLpro. Moreover by molecular dynamics simulation we demonstrated that currently available drugs acting as inhibitors of the SARS-CoV-2 main protease could be less effective in the case of Omicron variant due to the different chemical interactions in the binding site occurred after the recent amino acid mutations. Ultimately our study highlights the need of exploiting in silico and in vitro methods to discover novel 3CLpro inhibitors starting from the computationally based structure we presented herein and more in general to direct the major efforts to targeting the most conserved 3CLpro regions that appeared unchanged in the context of the Omicron variant.</p>
</section>
<section id="twitter" class="level2">
<h2 class="anchored" data-anchor-id="twitter">Twitter</h2>
<blockquote class="twitter-tweet blockquote">
<p lang="en" dir="ltr">
Computational insights on the destabilizing mutations in the binding site of 3CL-protease SARS-CoV-2 Omicron (VOC) <a href="https://t.co/m8yId9VYYT">https://t.co/m8yId9VYYT</a> <a href="https://twitter.com/hashtag/bioRxiv?src=hash&amp;ref_src=twsrc%5Etfw">#bioRxiv</a>
</p>
‚Äî bioRxiv (<span class="citation" data-cites="biorxivpreprint">(<strong>biorxivpreprint?</strong>)</span>) <a href="https://twitter.com/biorxivpreprint/status/1661580087924236288?ref_src=twsrc%5Etfw">May 25, 2023</a>
</blockquote>
<script async="" src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
<!--Include social share buttons-->
<!-- 
AddToAny check more: https://www.addtoany.com/buttons/for/website 
Using includes will make edits easier, will only need to add or remove button here if needed.
https://quarto.org/docs/authoring/includes.html
-->
<div class="a2a_kit a2a_kit_size_32 a2a_default_style">
<p><a class="a2a_dd" href="https://www.addtoany.com/share"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_mastodon"></a> <a class="a2a_button_facebook"></a> <a class="a2a_button_email"></a></p>
</div>
<script async="" src="https://static.addtoany.com/menu/page.js"></script>


</section>

<div id="quarto-appendix" class="default"><section class="quarto-appendix-contents"><h2 class="anchored quarto-appendix-heading">Citation</h2><div><div class="quarto-appendix-secondary-label">BibTeX citation:</div><pre class="sourceCode code-with-copy quarto-appendix-bibtex"><code class="sourceCode bibtex">@article{ullah* correspondence2023,
  author = {Ullah* correspondence, Samee},
  title = {Computational Insights on the Destabilizing Mutations in the
    Binding Site of {3CL-protease} {SARS-CoV-2} {Omicron} {(VOC)}},
  date = {2023-05-24},
  url = {https://www.biorxiv.org/content/10.1101/2023.05.24.542061v1},
  doi = {https://doi.org/10.1101/2023.05.24.542061},
  langid = {en}
}
</code></pre><div class="quarto-appendix-secondary-label">For attribution, please cite this work as:</div><div id="ref-ullah* correspondence2023" class="csl-entry quarto-appendix-citeas">
Ullah* correspondence, Samee. 2023. <span>‚ÄúComputational Insights on the
Destabilizing Mutations in the Binding Site of 3CL-Protease SARS-CoV-2
Omicron (VOC),‚Äù</span> May. https://doi.org/<a href="https://doi.org/10.1101/2023.05.24.542061">https://doi.org/10.1101/2023.05.24.542061</a>.
</div></div></section></div> ]]></description>
  <category>news</category>
  <category>events</category>
  <guid>https://ullahsamee.github.io/posts/2023-04-12-Computational-insights-on-destabilizing-mutations-in-bindingsite-3clprotease-sarscov2-omicron/index.html</guid>
  <pubDate>Tue, 23 May 2023 19:00:00 GMT</pubDate>
  <media:content url="https://ullahsamee.github.io/posts/2023-04-12-Computational-insights-on-destabilizing-mutations-in-bindingsite-3clprotease-sarscov2-omicron/featured.png" medium="image" type="image/png" height="144" width="144"/>
</item>
<item>
  <title>Participated in CryoEM introductory Workshop 2-4 Febraury 2022</title>
  <link>https://ullahsamee.github.io/posts/2022-12-energy-systems-analysis-open-course/index.html</link>
  <description><![CDATA[ 



<section id="workshop-zoom-linknow-expired" class="level2">
<h2 class="anchored" data-anchor-id="workshop-zoom-linknow-expired">Workshop zoom Link(now expired)</h2>
<p><a href="https://ucph-ku.zoom.us/j/62991965634?pwd=UkZHQ200UWVaQnR2RlBWb2RGV0JNdz09" target="_blank">https://ucph-ku.zoom.us/j/62991965634?pwd=UkZHQ200UWVaQnR2RlBWb2RGV0JNdz09</a></p>
</section>
<section id="agenda-of-the-workshop" class="level2">
<h2 class="anchored" data-anchor-id="agenda-of-the-workshop">Agenda of the Workshop</h2>
<section id="feb" class="level4">
<h4 class="anchored" data-anchor-id="feb"><strong>2-Feb</strong></h4>
<ul>
<li><p>9:00-9:15 Introduction (<a href="https://www.cpr.ku.dk/research/protein-structure-function-program/montoya/">Dr.&nbsp;Guillermo Montoya</a>)</p></li>
<li><p>9:15-9:30 Intro to CFIM (<a href="https://www.cpr.ku.dk/staff/montoya-group/?pure=en/persons/595110">Tillmann Pape</a>)</p></li>
<li><p>9:30-10:30 Lecture1: Sample preparation for single particle averaging (Tillmann Pape)</p></li>
<li><p>11:00-12:15 Lecture 2: Data collection strategies (Tillmann Pape)</p></li>
<li><p>13:15-14:45 Lecture 3: EM theory (transmission electron microscope, image formation, focus, phase contrast, contrast transfer function, image processing, resolution (<a href="https://www.cpr.ku.dk/research/protein-structure-function-program/taylor/">Nicholas Taylor</a>)</p></li>
</ul>
<p>Break</p>
<ul>
<li>15:45-17:00 Lecture 4: Cryo-electron tomography and subtomogram averaging. (<a href="https://www.cpr.ku.dk/staff/?pure=en/persons/303206">Simon Erlendsson</a>)</li>
</ul>
</section>
<section id="feb-1" class="level4">
<h4 class="anchored" data-anchor-id="feb-1"><strong>3-Feb</strong></h4>
<ul>
<li><p>9:00-10:30 Lecture 5: cryoSPARC (<a href="https://www.cpr.ku.dk/staff/?id=579310&amp;vis=medarbejder">Nicholas Sofos</a>)</p></li>
<li><p>11:00-12:30 Lecture 9: Alphafold in Model building (Chimera, ChimeraX &amp; Coot) (<a href="https://www.cpr.ku.dk/research/protein-structure-function-program/kummer/">Dr.Eva Kummer</a>)</p></li>
</ul>
<p>Lunch</p>
<ul>
<li>13:30-14:30 Lecture 10: X-ray crystallography, CryoEM, phasing and Phenix Refine (Guillermo Montoya)</li>
</ul>
</section>
<section id="feb-2" class="level4">
<h4 class="anchored" data-anchor-id="feb-2"><strong>4-Feb</strong></h4>
<ul>
<li><p>10:00-11:15 Lecture 6: CisTEM (<a href="https://www.cpr.ku.dk/staff/?pure=en%2Fpersons%2Fpablo-mesa(a2d4d7ab-b0f1-484c-a79e-cddd6444458c).html">Pablo Mesa</a>)</p></li>
<li><p>11:45-12:00 Lecture 7: Relion (Pablo Mesa)</p></li>
<li><p>13:00-14:00 Lecture 7: Relion (Pablo Mesa)</p></li>
</ul>
<p>Break</p>
<ul>
<li>14:30-15:30 Lecture 8: Introduction to cryoDRGN (Pablo Mesa)</li>
</ul>
<p>------Finished------</p>
<p>Here‚Äôs some nice clicks üì∏</p>
<p><img src="https://ullahsamee.github.io/posts/2022-12-energy-systems-analysis-open-course/images/4-01.png" class="img-fluid"></p>
<p><img src="https://ullahsamee.github.io/posts/2022-12-energy-systems-analysis-open-course/images/3.png" class="img-fluid"></p>
<p><img src="https://ullahsamee.github.io/posts/2022-12-energy-systems-analysis-open-course/1.png" class="img-fluid"></p>
<p><img src="https://ullahsamee.github.io/posts/2022-12-energy-systems-analysis-open-course/images/1.png" class="img-fluid"></p>
<p><img src="https://ullahsamee.github.io/posts/2022-12-energy-systems-analysis-open-course/images/Screenshot 2022161749.png" class="img-fluid"></p>
<p><img src="https://ullahsamee.github.io/posts/2022-12-energy-systems-analysis-open-course/images/Screenshot 2022-02-02 160444.png" class="img-fluid"></p>
<p><img src="https://ullahsamee.github.io/posts/2022-12-energy-systems-analysis-open-course/images/Screenshot 202.png" class="img-fluid"></p>
<p><img src="https://ullahsamee.github.io/posts/2022-12-energy-systems-analysis-open-course/images/Screenshot 2022-02-02.png" class="img-fluid"></p>
<p><img src="https://ullahsamee.github.io/posts/2022-12-energy-systems-analysis-open-course/images/Screenshot 2095028.png" class="img-fluid"></p>
<!--Include social share buttons-->
<!-- 
AddToAny check more: https://www.addtoany.com/buttons/for/website 
Using includes will make edits easier, will only need to add or remove button here if needed.
https://quarto.org/docs/authoring/includes.html
-->
<div class="a2a_kit a2a_kit_size_32 a2a_default_style">
<p><a class="a2a_dd" href="https://www.addtoany.com/share"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_mastodon"></a> <a class="a2a_button_facebook"></a> <a class="a2a_button_email"></a></p>
</div>
<script async="" src="https://static.addtoany.com/menu/page.js"></script>


</section>
</section>

 ]]></description>
  <category>news</category>
  <guid>https://ullahsamee.github.io/posts/2022-12-energy-systems-analysis-open-course/index.html</guid>
  <pubDate>Sun, 21 May 2023 19:00:00 GMT</pubDate>
  <media:content url="https://ullahsamee.github.io/posts/2022-12-energy-systems-analysis-open-course/featured.png" medium="image" type="image/png" height="80" width="144"/>
</item>
<item>
  <title>A novel de novo loss of function variant in the DNA-binding domain of TBX2 causes severe osteochondrodysplasia</title>
  <dc:creator>Samee Ullah</dc:creator>
  <link>https://ullahsamee.github.io/posts/2022-03-A-novel-denovo-loss-of-function-variant/index.html</link>
  <description><![CDATA[ 



<!--Include academic icons or bottons-->
<!-- 
Load Academicons v1: https://jpswalsh.github.io/academicons/
-->
<p><link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/jpswalsh/academicons@1/css/academicons.min.css"></p>
<p><link rel="stylesheet" href="http://maxcdn.bootstrapcdn.com/font-awesome/4.3.0/css/font-awesome.min.css"></p>
<!---
The following code are needed to show dimension citation and altmetrics.
https://api.altmetric.com/embeds.html
https://badge.dimensions.ai/
--->
<script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script>
<script async="" src="https://badge.dimensions.ai/badge.js" charset="utf-8"></script>
<div class="callout callout-style-default callout-note callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Paper
</div>
</div>
<div class="callout-body-container callout-body">
<p>Misbahuddin M Rafeeq, Hussam Aly Sayed Murad, <strong>Samee Ullah</strong>, Zaheer Ahmed, Qamre Alam, Muhammad Bilal, Alaa Hamed Habib, Ziaullah M Sain, Muhammad Jawad Khan, Muhammad Umair,<br>
<em>Frontiers in Genetics</em> (2022)<br>
DOI: <a href="https://www.frontiersin.org/articles/10.3389/fgene.2022.1117500/full">https://doi.org/10.3389/fgene.2022.1117500</a></p>
</div>
</div>
<section id="abstract" class="level2">
<h2 class="anchored" data-anchor-id="abstract">Abstract</h2>
<p>Background T-box family members are transcription factors characterized by highly conserved residues corresponding to the DNA-binding domain known as the T-box. TBX2 has been implicated in several developmental processes, such as coordinating cell fate, patterning, and morphogenesis of a wide range of tissues and organs, including lungs, limbs, heart, kidneys, craniofacial structures, and mammary glands.</p>
<p>Methods In the present study, we have clinically and genetically characterized a proband showing a severe form of chondrodysplasia with developmental delay. Whole-exome sequencing (WES), Sanger sequencing, and 3D protein modeling were performed in the present investigation.</p>
<p>Results Whole-exome sequencing revealed a novel nonsense variant (c.529A&gt;T; p.Lys177*; NM_005994.4) in TBX2. 3D-TBX2 protein modeling revealed a substantial reduction of the mutated protein, which might lead to a loss of function (LOF) or nonsense-mediated decay (NMD).</p>
<p>Conclusion This study has not only expanded the mutation spectrum in the gene TBX2 but also facilitated the diagnosis and genetic counseling of related features in affected families.</p>
</section>
<section id="links" class="level2">
<h2 class="anchored" data-anchor-id="links">Links</h2>
<p>Published <a href="https://www.frontiersin.org/articles/10.3389/fgene.2022.1117500/full">paper</a></p>
<p>Researchgate <a href="https://www.researchgate.net/publication/367206840_A_novel_de_novo_loss_of_function_variant_in_the_DNA-binding_domain_of_TBX2_causes_severe_osteochondrodysplasia?_sg%5B0%5D=yegY-KSBI16fEnAKniStG0rDpldFHWWVxpV33kcLv0Y8MeQjrDgNW4zEbzskdCJbz1JRfl29xnXlge11Y3A4dE1IUqoZ9YWUWOQGv5EC.g_Y2SPWFU7IOV4l15HeglmzaNMXHydHx5X7kMaVehYnQqrPNbu2txaopP6EFH5uQt08fuu0r_It_E6uOIhjMWw">pdf</a></p>
<script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script>
<div class="altmetric-embed" data-badge-popover="right" data-badge-type="donut" data-doi="https://doi.org/10.1016/j.molliq.2022.119393">

</div>
<script async="" src="https://badge.dimensions.ai/badge.js" charset="utf-8"></script>
<!--Include social share buttons-->
<!-- 
AddToAny check more: https://www.addtoany.com/buttons/for/website 
Using includes will make edits easier, will only need to add or remove button here if needed.
https://quarto.org/docs/authoring/includes.html
-->
<div class="a2a_kit a2a_kit_size_32 a2a_default_style">
<p><a class="a2a_dd" href="https://www.addtoany.com/share"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_mastodon"></a> <a class="a2a_button_facebook"></a> <a class="a2a_button_email"></a></p>
</div>
<script async="" src="https://static.addtoany.com/menu/page.js"></script>


</section>

<div id="quarto-appendix" class="default"><section class="quarto-appendix-contents"><h2 class="anchored quarto-appendix-heading">Citation</h2><div><div class="quarto-appendix-secondary-label">BibTeX citation:</div><pre class="sourceCode code-with-copy quarto-appendix-bibtex"><code class="sourceCode bibtex">@article{ullah2022,
  author = {Ullah, Samee},
  title = {A Novel de Novo Loss of Function Variant in the {DNA-binding}
    Domain of {TBX2} Causes Severe Osteochondrodysplasia},
  volume = {13},
  number = {1117500},
  date = {2022-03-01},
  url = {https://www.frontiersin.org/articles/10.3389/fgene.2022.1117500/full},
  doi = {10.3389/fgene.2022.1117500},
  langid = {en}
}
</code></pre><div class="quarto-appendix-secondary-label">For attribution, please cite this work as:</div><div id="ref-ullah2022" class="csl-entry quarto-appendix-citeas">
Ullah, Samee. 2022. <span>‚ÄúA Novel de Novo Loss of Function Variant in
the DNA-Binding Domain of TBX2 Causes Severe
Osteochondrodysplasia‚Äù</span> 13 (1117500). <a href="https://doi.org/10.3389/fgene.2022.1117500">https://doi.org/10.3389/fgene.2022.1117500</a>.
</div></div></section></div> ]]></description>
  <category>paper</category>
  <guid>https://ullahsamee.github.io/posts/2022-03-A-novel-denovo-loss-of-function-variant/index.html</guid>
  <pubDate>Mon, 28 Feb 2022 19:00:00 GMT</pubDate>
  <media:content url="https://ullahsamee.github.io/posts/2022-03-A-novel-denovo-loss-of-function-variant/featured.png" medium="image" type="image/png" height="77" width="144"/>
</item>
<item>
  <title>Computational prediction of potential drug-like compounds from Cannabis sativa leaf extracts targeted towards Alzheimer therapy</title>
  <dc:creator>Samee Ullah</dc:creator>
  <link>https://ullahsamee.github.io/posts/2022-03-computational-prediction-of-potential-drug-like-compounds/index.html</link>
  <description><![CDATA[ 



<!--Include academic icons or bottons-->
<!-- 
Load Academicons v1: https://jpswalsh.github.io/academicons/
-->
<p><link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/jpswalsh/academicons@1/css/academicons.min.css"></p>
<p><link rel="stylesheet" href="http://maxcdn.bootstrapcdn.com/font-awesome/4.3.0/css/font-awesome.min.css"></p>
<!---
The following code are needed to show dimension citation and altmetrics.
https://api.altmetric.com/embeds.html
https://badge.dimensions.ai/
--->
<script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script>
<script async="" src="https://badge.dimensions.ai/badge.js" charset="utf-8"></script>
<div class="callout callout-style-default callout-note callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Paper
</div>
</div>
<div class="callout-body-container callout-body">
<p>Adewale Oluwaseun Fadaka, Odunayo Anthonia Taiwo, Oluwatosin Adebisi Dosumu, Oluwafemi Paul Owolabi, Adebola Busola Ojo, Nicole Remaliah Samantha Sibuyi, <strong>Samee Ullah</strong>, Ashwil Klein, Abram Madimabe Madiehe, Mervin Meyer, Oluwafemi Adeleke Ojo,<br>
<em>Journal of Molecular liquids</em> (2022)<br>
DOI: <a href="https://www.sciencedirect.com/science/article/abs/pii/S016773222200931X">https://doi.org/10.1016/j.molliq.2022.119393</a></p>
</div>
</div>
<section id="abstract" class="level2">
<h2 class="anchored" data-anchor-id="abstract">Abstract</h2>
<p>This study was aimed at evaluating the inhibitory effects of the phytochemicals from the Cannabis sativa (Cannabis) leaf extracts against Alzheimer‚Äôs disease (AD) protein targets. Twelve compounds derived from the Cannabis sativa leaf extracts were evaluated as potential inhibitors of acetylcholinesterase (AChE), dopa decarboxylase (DDC), serotonin receptor 2C (HTR2C) and monoamine oxidase (MAO). Ligand-based and receptor-ligand complex were used to derive the pharmacophore hypothesis. In silico study through molecular docking simulation method was adopted to analyze the inhibitory activity of the compounds in question. Molecular dynamic simulation (MDs) was performed to assess the stability of the top-ranked phytochemicals. The binding energies of these compounds to the four targets were investigated by the Molecular Mechanics for the Generalized Born Model and Solvent Accessibility method (MM-GBSA). The binding-free energy suggests that cannabinol, cannabichromene, linoelaidic acid and morphinan-6-one can be utilized as lead compounds in drug discovery and development of AD to inhibit activity of AChE, DCC gene, MAO and HTR2C. The MDs indicated that AChE-Cannabinol, DCC-Cannabicoumaronone, MAO-Linoelaidic acid, and HTR2C-morphinan-6-one were stable over the entire course of 100 ns suggesting their role in the regulation of the diseases in which their respective receptors are implicated.</p>
</section>
<section id="links" class="level2">
<h2 class="anchored" data-anchor-id="links">Links</h2>
<p>Published <a href="https://www.sciencedirect.com/science/article/abs/pii/S016773222200931X">paper</a></p>
<p>Researchgate <a href="https://www.researchgate.net/publication/360637789_Computational_Prediction_of_Potential_Drug-like_Compounds_from_Cannabis_sativa_Leaf_Extracts_Targeted_towards_Alzheimer_Therapy">pdf</a></p>
<script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script>
<div class="altmetric-embed" data-badge-popover="right" data-badge-type="donut" data-doi="https://doi.org/10.1016/j.molliq.2022.119393">

</div>
<script async="" src="https://badge.dimensions.ai/badge.js" charset="utf-8"></script>
<!--Include social share buttons-->
<!-- 
AddToAny check more: https://www.addtoany.com/buttons/for/website 
Using includes will make edits easier, will only need to add or remove button here if needed.
https://quarto.org/docs/authoring/includes.html
-->
<div class="a2a_kit a2a_kit_size_32 a2a_default_style">
<p><a class="a2a_dd" href="https://www.addtoany.com/share"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_mastodon"></a> <a class="a2a_button_facebook"></a> <a class="a2a_button_email"></a></p>
</div>
<script async="" src="https://static.addtoany.com/menu/page.js"></script>


</section>

<div id="quarto-appendix" class="default"><section class="quarto-appendix-contents"><h2 class="anchored quarto-appendix-heading">Citation</h2><div><div class="quarto-appendix-secondary-label">BibTeX citation:</div><pre class="sourceCode code-with-copy quarto-appendix-bibtex"><code class="sourceCode bibtex">@article{ullah2022,
  author = {Ullah, Samee},
  title = {Computational Prediction of Potential Drug-Like Compounds
    from {Cannabis} Sativa Leaf Extracts Targeted Towards {Alzheimer}
    Therapy},
  volume = {360},
  number = {119393},
  date = {2022-03-01},
  url = {https://www.sciencedirect.com/science/article/abs/pii/S016773222200931X?via%3Dihub},
  doi = {10.1038/s41586-022-05316-6},
  langid = {en}
}
</code></pre><div class="quarto-appendix-secondary-label">For attribution, please cite this work as:</div><div id="ref-ullah2022" class="csl-entry quarto-appendix-citeas">
Ullah, Samee. 2022. <span>‚ÄúComputational Prediction of Potential
Drug-Like Compounds from Cannabis Sativa Leaf Extracts Targeted Towards
Alzheimer Therapy‚Äù</span> 360 (119393). <a href="https://doi.org/10.1038/s41586-022-05316-6">https://doi.org/10.1038/s41586-022-05316-6</a>.
</div></div></section></div> ]]></description>
  <category>paper</category>
  <guid>https://ullahsamee.github.io/posts/2022-03-computational-prediction-of-potential-drug-like-compounds/index.html</guid>
  <pubDate>Mon, 28 Feb 2022 19:00:00 GMT</pubDate>
  <media:content url="https://ullahsamee.github.io/posts/2022-03-computational-prediction-of-potential-drug-like-compounds/featured.png" medium="image" type="image/png" height="101" width="144"/>
</item>
<item>
  <title>Novel insights on nucleopeptide binding: A spectroscopic and in silico investigation on the interaction of a thymine-bearing tetrapeptide with a homoadenine DNA</title>
  <dc:creator>Samee Ullah</dc:creator>
  <link>https://ullahsamee.github.io/posts/2022-10-Novel-insights-on-nucleopeptide-binding-insilico-investigation-of-thymine-bearing-tetrapeptide/index.html</link>
  <description><![CDATA[ 



<!--Include academic icons or bottons-->
<!-- 
Load Academicons v1: https://jpswalsh.github.io/academicons/
-->
<p><link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/jpswalsh/academicons@1/css/academicons.min.css"></p>
<p><link rel="stylesheet" href="http://maxcdn.bootstrapcdn.com/font-awesome/4.3.0/css/font-awesome.min.css"></p>
<!---
The following code are needed to show dimension citation and altmetrics.
https://api.altmetric.com/embeds.html
https://badge.dimensions.ai/
--->
<script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script>
<script async="" src="https://badge.dimensions.ai/badge.js" charset="utf-8"></script>
<div class="callout callout-style-default callout-note callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Paper
</div>
</div>
<div class="callout-body-container callout-body">
<p>Domenica Musumeci, <strong>Samee Ullah</strong>, Aamer Ikram, Giovanni N Roviello<br>
<em>Journal of Molecular Liquids</em> (2022)<br>
DOI: <a href="https://doi.org/10.1016/j.molliq.2021.117975">https://doi.org/10.1016/j.molliq.2021.117975</a><br>
<!--<i class="fa fa-download"></i> [PDF](/files/papers/2022-10-Novel-insights-on-nucleopeptide-binding-insilico-investigation-of-thymine-bearing-tetrapeptide) &nbsp; <i class="fa-brands fa-github"></i> --></p>
</div>
</div>
<section id="abstract" class="level2">
<h2 class="anchored" data-anchor-id="abstract">Abstract</h2>
<p>Nucleopeptides are a class of molecules with numerous applications in the field of therapy, diagnostics and biomaterials development. Despite their nucleobase-decorated nature, their binding to natural nucleic acid targets does not necessarily involve all nucleopeptide bases, as we showed in this study. Here, we present a CD study on the interaction of a dithymine-functionalized tetra-L-serine with a homoadenine DNA (dA12) reporting an interpretation of the experimental data in light of our computational studies based on molecular docking and molecular dynamics (MD), as well as computer-assisted CD interpretation and simulation of the predicted complex structure. The stoichiometry of the complex, emerged by CD titration, accounted for a 1:2 T:A ratio. Hence, we supposed that binding did not involve a full pairing of the complementary bases but a partial thymines engagement. This hypothesis was sustained by the docking and MD simulations performed on the selected ligand and the complementary target of DNA and RNA, used for comparison. The nucleopeptide bound the DNA through a single A-T recognition involving complementary base-pairing, as well as by some interactions between its backbone (and in particular L-serine OH) and the nucleic acid. Overall, this confirmed that nucleopeptides can interact with nucleic acids leaving some of their nucleobases free for establishing further interactions with other biomolecules or for crosslinking in supramolecular structures in aqueous solution. Nevertheless, even though no typical DNA secondary structure is formed after nucleopeptide-binding, this ligand is able to induce a higher degree of structuration in the random deoxyoligonucleotide target as evidenced by CD, MD and CD simulation.</p>
</section>
<section id="links" class="level2">
<h2 class="anchored" data-anchor-id="links">Links</h2>
<p>Published <a href="https://www.sciencedirect.com/science/article/abs/pii/S0167732221027008">paper</a></p>
<p>ResearchGate <a href="https://www.researchgate.net/publication/355745695_Novel_insights_on_nucleopeptide_binding_A_spectroscopic_and_in_silico_investigation_on_the_interaction_of_a_thymine-bearing_tetrapeptide_with_a_homoadenine_DNA">pdf</a> provided by <em>Elsevier</em></p>
<!--Include social share buttons-->
<!-- 
AddToAny check more: https://www.addtoany.com/buttons/for/website 
Using includes will make edits easier, will only need to add or remove button here if needed.
https://quarto.org/docs/authoring/includes.html
-->
<div class="a2a_kit a2a_kit_size_32 a2a_default_style">
<p><a class="a2a_dd" href="https://www.addtoany.com/share"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_mastodon"></a> <a class="a2a_button_facebook"></a> <a class="a2a_button_email"></a></p>
</div>
<script async="" src="https://static.addtoany.com/menu/page.js"></script>
<!---
## Timeline

The following timeline from Researchsquare might provide a reference point when tracking submitted manuscript.

| Version | Date     | Status                                       | Days since this submission | Days since first submission |
|---------|----------|----------------------------------------------|----------------------------|-----------------------------|
| 1       | 8/16/21  | First submitted to Nature                    |                            |                             |
| 1       | 8/16/21  | Editor assigned                              | 0                          | 0                           |
| 1       | 8/29/21  | 8 reviewer(s) invited                        | 13                         | 13                          |
| 1       | 8/31/21  | Reviewer #1 agreed                           | 15                         | 15                          |
| 1       | 9/1/21   | Reviewer #2 agreed                           | 16                         | 16                          |
| 1       | 9/15/21  | Review #1 received                           | 30                         | 30                          |
| 1       | 9/17/21  | Review #2 received                           | 32                         | 32                          |
| 1       | 10/13/21 | Reviewer #3 agreed                           | 58                         | 58                          |
| 1       | 10/13/21 | Review #3 received                           | 58                         | 58                          |
| 1       | 11/10/21 | Editorial decision: Reject                   | 86                         | 86                          |
| 2       | 3/28/22  | Version 2 submitted to Nature                |                            | 224                         |
| 2       | 3/31/22  | 3 reviewer(s) invited                        | 3                          | 227                         |
| 2       | 4/1/22   | Reviewer #1 agreed                           | 4                          | 228                         |
| 2       | 4/7/22   | Reviewer #2 agreed                           | 10                         | 234                         |
| 2       | 4/19/22  | Review #2 received                           | 22                         | 246                         |
| 2       | 4/24/22  | Review #1 received                           | 27                         | 251                         |
| 2       | 4/24/22  | Editorial decision: Reject                   | 27                         | 251                         |
| 3       | 6/11/22  | Version 3 submitted to Nature                |                            | 299                         |
| 3       | 6/14/22  | 4 reviewer(s) invited                        | 3                          | 320                         |
| 3       | 7/5/22   | Reviewer #1 agreed                           | 24                         | 323                         |
| 3       | 7/6/22   | Review #1 received                           | 25                         | 324                         |
| 3       | 7/20/22  | Reviewer #2 agreed                           | 39                         | 338                         |
| 3       | 7/28/22  | Review #2 received                           | 47                         | 346                         |
| 3       | 7/29/22  | Reviewer #3 agreed                           | 48                         | 347                         |
| 3       | 8/8/22   | Review #3 received                           | 58                         | 357                         |
| 3       | 8/9/22   | Editorial decision: Revise                   | 59                         | 358                         |
| 4       | 8/15/22  | Version 4 submitted to Nature                |                            | 364                         |
| 4       | 8/16/22  | 1 reviewer(s) invited                        | 1                          | 365                         |
| 4       | 8/16/22  | Reviewer #1 agreed                           | 1                          | 365                         |
| 4       | 8/17/22  | Review #1 received                           | 2                          | 366                         |
| 4       | 9/2/22   | Editorial decision: Accept                   | 18                         | 382                         |
| 5       | 9/28/22  | Proofs received                              |                            | 408                         |
| 6       | 10/26/22 | Published online                             |                            | 436                         |
--->


</section>

<div id="quarto-appendix" class="default"><section class="quarto-appendix-contents"><h2 class="anchored quarto-appendix-heading">Citation</h2><div><div class="quarto-appendix-secondary-label">BibTeX citation:</div><pre class="sourceCode code-with-copy quarto-appendix-bibtex"><code class="sourceCode bibtex">@article{ullah2022,
  author = {Ullah, Samee},
  title = {Novel Insights on Nucleopeptide Binding: {A} Spectroscopic
    and in Silico Investigation on the Interaction of a Thymine-Bearing
    Tetrapeptide with a Homoadenine {DNA}},
  volume = {347},
  number = {117975},
  date = {2022-02-01},
  url = {https://www.sciencedirect.com/science/article/abs/pii/S0167732221027008},
  doi = {10.1038/s41586-022-05316-6},
  langid = {en}
}
</code></pre><div class="quarto-appendix-secondary-label">For attribution, please cite this work as:</div><div id="ref-ullah2022" class="csl-entry quarto-appendix-citeas">
Ullah, Samee. 2022. <span>‚ÄúNovel Insights on Nucleopeptide Binding: A
Spectroscopic and in Silico Investigation on the Interaction of a
Thymine-Bearing Tetrapeptide with a Homoadenine DNA‚Äù</span> 347
(117975). <a href="https://doi.org/10.1038/s41586-022-05316-6">https://doi.org/10.1038/s41586-022-05316-6</a>.
</div></div></section></div> ]]></description>
  <category>paper</category>
  <guid>https://ullahsamee.github.io/posts/2022-10-Novel-insights-on-nucleopeptide-binding-insilico-investigation-of-thymine-bearing-tetrapeptide/index.html</guid>
  <pubDate>Mon, 31 Jan 2022 19:00:00 GMT</pubDate>
  <media:content url="https://ullahsamee.github.io/posts/2022-10-Novel-insights-on-nucleopeptide-binding-insilico-investigation-of-thymine-bearing-tetrapeptide/featured.png" medium="image" type="image/png" height="92" width="144"/>
</item>
<item>
  <title>Importation of SARS-CoV-2 Variant B.1.1.7 in Pakistan</title>
  <dc:creator>Samee Ullah</dc:creator>
  <link>https://ullahsamee.github.io/posts/2022-12-Importation-of-b117-variant/index.html</link>
  <description><![CDATA[ 



<!--Include academic icons or bottons-->
<!-- 
Load Academicons v1: https://jpswalsh.github.io/academicons/
-->
<p><link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/jpswalsh/academicons@1/css/academicons.min.css"></p>
<p><link rel="stylesheet" href="http://maxcdn.bootstrapcdn.com/font-awesome/4.3.0/css/font-awesome.min.css"></p>
<!---
The following code are needed to show dimension citation and altmetrics.
https://api.altmetric.com/embeds.html
https://badge.dimensions.ai/
--->
<script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script>
<script async="" src="https://badge.dimensions.ai/badge.js" charset="utf-8"></script>
<div class="callout callout-style-default callout-note callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
Paper (LETTER TO THE EDITOR)
</div>
</div>
<div class="callout-body-container callout-body">
<p>Massab Umair, Aamer Ikram, Muhammad Salman, Muhammad Masroor Alam, Nazish Badar, Zaira Rehman, Sana Tamim, Adnan Khurshid, Abdul Ahad, Hamza Ahmad, <strong>Samee Ullah</strong>,<br>
<em>Journal of Medical Virology</em> (2021)<br>
DOI: <a href="https://onlinelibrary.wiley.com/doi/10.1002/jmv.26869">https://doi.org/10.1002/jmv.26869</a></p>
</div>
</div>
<section id="abstract" class="level2">
<h2 class="anchored" data-anchor-id="abstract">Abstract</h2>
<p>On December 14, 2020, a variant of SARS‚ÄêCoV‚Äê2 characterized as VOC‚Äê202012/01 (lineage B.1.1.7) emerged in the United Kingdom with rapid expansion to over 64 countries as of January 27, 2021. (<a href="https://www.gisaid.org/" class="uri">https://www.gisaid.org/</a>). Analysis of 17,782 whole‚Äêgenome sequences submitted to GISAID exhibited several mutations mainly in the spike (S) gene. During the current COVID‚Äê19 pandemic, identification of novel lineages of SARS‚ÄêCoV‚Äê2 and tracking their geographic spread are essential to guide public health interventions and travel advice. We hereby report the detection and genetic characterization of two imported cases of the B.1.1.7 variant in Pakistan.</p>
<p>The oropharyngeal swabs of travelers returning from United Kingdom were tested for the presence of SARS‚ÄêCoV‚Äê2 through real‚Äêtime polymerase chain reaction (PCR) at the Department of Virology, National Institute of Health, Pakistan. Briefly, viral RNA was extracted using QIAamp Viral RNA Mini kit (Qiagen) according to manufacturer‚Äôs instructions. A two‚Äêstep strategy was used for the detection of the SARS‚ÄêCoV‚Äê2 variant B.1.1.7 with initial screening by TaqPath‚Ñ¢ RT‚ÄêPCR COVID‚Äê19 kit (Thermo Fisher Scientific) followed by whole genome sequencing of spike gene target failure (SGTF) samples. The NEBNext Ultra II Directional RNA Library Prep kit for Illumina (NEW ENGLAND BioLabs Inc.) was used for library preparation according to manufacturer‚Äôs instructions and whole‚Äêgenome sequencing was performed on Illumina iSeq 100 instrument (Illumina). Sequence alignment and analysis was performed using Geneious prime software version 2020.1.2 (<a href="https://www.geneious.com/prime/" class="uri">https://www.geneious.com/prime/</a>).</p>
<p>Between December 28, 2020 and January 03, 2021, a total of 76 samples from travelers returning from the United Kingdom were received and tested among which 38 (50%) were found SARS‚ÄêCoV‚Äê2 positive on real‚Äêtime PCR (showing amplification of all three targets, i.e., N gene, ORF1ab and the S gene) whereas 10 (26%) samples showed the SGTF. Only six SGTF samples having low <em>C</em>t values of N gene (&lt;25) were further subjected to next generation sequencing and two samples were successfully sequenced.</p>
<p>The two Pakistan strains MU‚ÄêNIH‚ÄêK14 and MU‚ÄêNIH‚ÄêK53 showed 99.9% nucleotide homology with the UK prototype variant (VOC‚Äê202012/01). Phylogenetic analysis categorized Pakistani strains to B.1.1.7 lineage indicating two independent introductions that clustered with strains from Luxembourg, Spain, and United States, respectively (Figure&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013196/figure/jmv26869-fig-0001/">1</a>). Overall, the two strains showed 19 missense mutations, 6 amino acid deletions, and 5 synonymous mutations (Table&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013196/table/jmv26869-tbl-0001/">1</a>). Notably, we found the N501Y mutation in the receptor binding domain of spike protein known to escalate viral binding with angiotensin‚Äêconverting enzyme 2 receptor, increase transmissibility and enables the virus to escape class 1 antibodies.</p>
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="https://ullahsamee.github.io/posts/2022-12-Importation-of-b117-variant/images/figure1.jpg" class="img-fluid figure-img"></p>
<figcaption class="figure-caption">Phylogenetic tree of B.1.1.7 variant viruses. For phylogenetic analysis, Wuhan reference SARS‚ÄêCoV‚Äê2 (EPI_ISL_529213) sequence and whole genome sequences of B.1.1.7 SARS‚ÄêCoV‚Äê2 strain deposited on GISAID till January 8, 2021 were downloaded followed by multiple sequence alignment using MAFTT. The phylogenetic tree was constructed using BEAST to estimate divergence times. The Pakistani sequences are highlighted in green color. The tree was edited and visualized using Figtree software (http://tree.bio.ed.ac.uk/software/figtree/). A timescale for evolution of strain is shown at the bottom of tree. Complete genome sequences of SARS‚ÄêCoV‚Äê2 B.1.1.7 strains (MU‚ÄêNIH‚ÄêK14 &amp; MU‚ÄêNIH‚ÄêK53) are deposited at the GISAID having accession ID‚Äôs EPI_ISL_757258 and EPI_ISL_757286</figcaption>
</figure>
</div>
<p>Our sequences MU‚ÄêNIH‚ÄêK14 and MU‚ÄêNIH‚ÄêK53 also showed a spike protein P618H substitution reported as a key determinant for efficient SARS‚ÄêCoV‚Äê2 transmission and deletion at amino acid 69‚Äì70 that has implications for diagnostic assays.</p>
<p>Whilst the full implication and functional significance of such variants is yet to be determined, these findings warrant to scale‚Äêup the molecular surveillance system in Pakistan to enable early detection of emerging lineages and their clinical impact. As of to date, there is a single public health federal institute (NIH) resourced to characterize SARS‚ÄêCoV‚Äê2 variants. The national authorities should proactively focus on expanding genomic surveillance of SARS‚ÄêCoV‚Äê2 to fortify global containment efforts in identifying epidemiologically and clinically significant variants and track their transmission lineages for effective countermeasures.</p>
<p>Notably, Pakistan has yet to devise its vaccination strategy using an economical and community acceptable vaccine before the immunization kicks off in the country. Pakistan, since September 2020, is conducting a phase‚ÄêIII clinical trial of a single‚Äêdose anti‚ÄêCOVID vaccine manufactured by a Chinese producer CanSino with 18,000 volunteers mainly in the Federal capital. Another phase‚ÄêI trial of a different Chinese vaccine SinoVac has been completed in district Karachi. With such encouraging decisions by the Government of Pakistan to boost the herd immunity and protection through vaccination preferably through a Chinese manufacturer, alarming news came out of a phase‚ÄêIII trial of the Chinese Coronavac vaccine in Brazil with only 50% efficacy compared to western counterparts, that is, Moderna and Pfizer‚ÄêBioNTech with 95% efficacy. It is, therefore, critical to reconsider the selection of vaccine to win public acceptance at large in view of the chronic reluctance impeding polio eradication in the country for years.</p>
</section>
<section id="links" class="level2">
<h2 class="anchored" data-anchor-id="links">Links</h2>
<p>Published <a href="https://onlinelibrary.wiley.com/doi/10.1002/jmv.26869">paper</a></p>
<p>Researchgate <a href="https://www.researchgate.net/publication/349220095_Importation_of_SARS-CoV-2_Variant_B117_in_Pakistan">pdf</a></p>
<script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script>
<div class="altmetric-embed" data-badge-popover="right" data-badge-type="donut" data-doi="https://doi.org/10.1016/j.molliq.2022.119393">

</div>
<script async="" src="https://badge.dimensions.ai/badge.js" charset="utf-8"></script>
<!--Include social share buttons-->
<!-- 
AddToAny check more: https://www.addtoany.com/buttons/for/website 
Using includes will make edits easier, will only need to add or remove button here if needed.
https://quarto.org/docs/authoring/includes.html
-->
<div class="a2a_kit a2a_kit_size_32 a2a_default_style">
<p><a class="a2a_dd" href="https://www.addtoany.com/share"></a> <a class="a2a_button_twitter"></a> <a class="a2a_button_linkedin"></a> <a class="a2a_button_mastodon"></a> <a class="a2a_button_facebook"></a> <a class="a2a_button_email"></a></p>
</div>
<script async="" src="https://static.addtoany.com/menu/page.js"></script>


</section>

<div id="quarto-appendix" class="default"><section class="quarto-appendix-contents"><h2 class="anchored quarto-appendix-heading">Citation</h2><div><div class="quarto-appendix-secondary-label">BibTeX citation:</div><pre class="sourceCode code-with-copy quarto-appendix-bibtex"><code class="sourceCode bibtex">@article{ullah2021,
  author = {Ullah, Samee},
  title = {Importation of {SARS-CoV-2} {Variant} {B.1.1.7} in
    {Pakistan}},
  volume = {93},
  number = {5},
  date = {2021-02-11},
  url = {https://onlinelibrary.wiley.com/doi/10.1002/jmv.26869},
  doi = {10.1002/jmv.26869},
  langid = {en}
}
</code></pre><div class="quarto-appendix-secondary-label">For attribution, please cite this work as:</div><div id="ref-ullah2021" class="csl-entry quarto-appendix-citeas">
Ullah, Samee. 2021. <span>‚ÄúImportation of SARS-CoV-2 Variant B.1.1.7 in
Pakistan‚Äù</span> 93 (5). <a href="https://doi.org/10.1002/jmv.26869">https://doi.org/10.1002/jmv.26869</a>.
</div></div></section></div> ]]></description>
  <category>paper</category>
  <guid>https://ullahsamee.github.io/posts/2022-12-Importation-of-b117-variant/index.html</guid>
  <pubDate>Wed, 10 Feb 2021 19:00:00 GMT</pubDate>
  <media:content url="https://ullahsamee.github.io/posts/2022-12-Importation-of-b117-variant/featured.png" medium="image" type="image/png" height="112" width="144"/>
</item>
</channel>
</rss>
